Who
Sven Wehrwein
Director
Company insider
Files Form 4 as: Director, AtriCure; Director, Proto Labs; Director, SPS Commerce; Director, Cogentix Medical Inc /de/; Director, Uroplasty; Director, Synovis Life Technologies; Director, Vital Images; Director, Autoscope Technologies.
In numbers
- Trades disclosed
- 356
- Buys
- 1
- Sells
- 71
- Bought
- $4,900
- Sold
- $13.7M
- Companies
- 9
- Companies where not an officer
- 9
- First trade
- 14 Mar 2006
- Last trade
- 28 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Jul 2026filed 30 Jul 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code M | $499K25,000 at $19.95 | filing |
| 28 Jul 2026filed 30 Jul 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $946K25,000 at $37.84 | filing |
| 28 Jul 2026filed 30 Jul 2026 | ATRC AtriCureoption or derivative · Medical Devices | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 28 Jul 2026filed 30 Jul 2026 | ATRC AtriCureoption or derivative · Medical Devices | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 28 Jul 2026filed 30 Jul 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code M | $499K25,000 at $19.95 | filing |
| 28 Jul 2026filed 30 Jul 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $946K25,000 at $37.84 | filing |
| 2 Jun 2026filed 4 Jun 2026 | PRLB Proto LabsMachinery | SEC FORM 4 Sold | $115K1,500 at $76.91 | filing |
| 2 Jun 2026filed 4 Jun 2026 | PRLB Proto LabsMachinery | SEC FORM 4 Sold | $39K500 at $78.38 | filing |
| 2 Jun 2026filed 4 Jun 2026 | PRLB Proto LabsMachinery | SEC FORM 4 Sold | $115K1,500 at $76.91 | filing |
| 2 Jun 2026filed 4 Jun 2026 | PRLB Proto LabsMachinery | SEC FORM 4 Sold | $39K500 at $78.38 | filing |
| 19 May 2026filed 21 May 2026 | PRLB Proto LabsMachinery | SEC FORM 4 Code A | —2,210 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | PRLB Proto LabsMachinery | SEC FORM 4 Code A | —2,210 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —6,144 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —6,144 at $0.00 | filing |
| 25 Nov 2025filed 26 Nov 2025 | ATRC AtriCureoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,967 at $0.00 | filing |
| 25 Nov 2025filed 26 Nov 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Code M | $99K4,967 at $19.95 | filing |
| 25 Nov 2025filed 26 Nov 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $189K4,967 at $38.00 | filing |
| 24 Nov 2025filed 26 Nov 2025 | ATRC AtriCureoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,033 at $0.00 | filing |
| 24 Nov 2025filed 26 Nov 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Code M | $100K5,033 at $19.95 | filing |
| 24 Nov 2025filed 26 Nov 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $188K5,033 at $37.32 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)ATRC · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Sven Wehrwein; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.